Nexentis Technologies (NASDAQ:NXTS) versus Eton Pharmaceuticals (NASDAQ:ETON) Head-To-Head Contrast

Eton Pharmaceuticals (NASDAQ:ETON) and Nexentis Technologies (NASDAQ:NXTS) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst recommendations, earnings and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Eton Pharmaceuticals and Nexentis Technologies, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eton Pharmaceuticals	0	2	4	0	2.67
Nexentis Technologies	1	0	0	0	1.00

Eton Pharmaceuticals currently has a consensus target price of $67.50, indicating a potential upside of 26.57%. Given Eton Pharmaceuticals’ stronger consensus rating and higher probable upside, analysts plainly believe Eton Pharmaceuticals is more favorable than Nexentis Technologies.

Profitability

This table compares Eton Pharmaceuticals and Nexentis Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Eton Pharmaceuticals	12.02%	40.13%	12.37%
Nexentis Technologies	N/A	-304.79%	-178.91%

Volatility & Risk

Eton Pharmaceuticals has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500. Comparatively, Nexentis Technologies has a beta of 1.84, meaning that its share price is 84% more volatile than the S&P 500.

Institutional & Insider Ownership

27.9% of Eton Pharmaceuticals shares are owned by institutional investors. Comparatively, 61.2% of Nexentis Technologies shares are owned by institutional investors. 16.5% of Eton Pharmaceuticals shares are owned by insiders. Comparatively, 6.5% of Nexentis Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Eton Pharmaceuticals and Nexentis Technologies”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eton Pharmaceuticals	$79.95 million	19.06	-$4.60 million	$0.38	140.34
Nexentis Technologies	N/A	N/A	-$4.00 million	($96.07)	-0.01

Nexentis Technologies has lower revenue, but higher earnings than Eton Pharmaceuticals. Nexentis Technologies is trading at a lower price-to-earnings ratio than Eton Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Summary

Eton Pharmaceuticals beats Nexentis Technologies on 10 of the 13 factors compared between the two stocks.

About Eton Pharmaceuticals

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

About Nexentis Technologies

N2OFF, Inc., an agri-food tech company, engages in the development and sale of eco-friendly green solutions for the food industry to enhance food safety and shelf life of fresh produce. Its products are based on proprietary blend of food acids combined with various oxidizing agent-based sanitizers and low concentrated fungicides for cleaning, sanitizing, and controlling pathogens on fresh produce that are safer for human consumption and extend their shelf life by reducing their decay. The company’s products include SavePROTECT or PeroStar, a processing aid for post-harvest application that is added to fruit and vegetable wash water; and SF3HS and SF3H, a post-harvest cleaning and sanitizing solution to control plant and foodborne pathogens. It also offers SpuDefender for controlling post-harvest potato sprouts; and FreshProtect to control spoilage-creating microorganisms on post-harvest citrus fruit. The company was formerly known as Save Foods, Inc. and changed its name to N2OFF, Inc. in March 2024. N2OFF, Inc. was incorporated in 2009 and is headquartered in Hod HaSharon, Israel.